You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
By Inderes
Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.
Life Science Night
Keynote – Antti Siltanen, Inderes (link)
Aiforia – Jukka Tapaninen, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
Faron Pharmaceuticals – Juho Jalkanen, CEO (link)
Life Science Night December 2, 2024 (link)
Health Technology & Pharmaceutical Developer Night December 11, 2023 (link)
Health Technology & Pharmaceutical Developer Night December 13, 2022 (link)
Roblon – Præsentation af årsregnskabet for 2023/24
Dustin Group, Audiocast with teleconference, Q1'25
Aktier i Vælten - Et tilbageblik på bevægelserne i OMXC25 i 2024, og nogle forudsigelser for 2025
5 forudsigelser for aktiemarkedet i 2025
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
View all videos